Literature DB >> 30554970

Metronidazole aryloxy, carboxy and azole derivatives: Synthesis, anti-tumor activity, QSAR, molecular docking and dynamics studies.

Ehsan Faghih-Mirzaei1, Salehe Sabouri2, Leila Zeidabadinejad3, Salman AbdolahRamazani4, Mehdi Abaszadeh5, Arash Khodadadi6, Mohadeseh Shamsadinipour6, Mandana Jafari7, Somayeh Pirhadi8.   

Abstract

A series of novel metronidazole aryloxy, carboxy and azole derivatives has been synthesized and their cytotoxic activities on three cancer cell lines were evaluated by MTT assay. Compounds 4m, 4l and 4d showed the most potent cytotoxic activity (IC50s less than 100 µg/mL). Apoptosis was also detected for these compounds by flow cytometry. Docking studies were performed in order to propose the probable target protein. In the next step, molecular dynamics simulation was carried out on the proposed target protein, focal adhesion kinase (FAK, PDB code: 2ETM), bound to compound 4m. As, 4m showed a potent cytotoxic activity and an acceptable apoptotic effect, it can be a potential anticancer candidate that may work through inhibition of FAK.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Apoptosis; Cancer; Docking; MTT; Metronidazole; Molecular dynamics simulation; QSAR; Synthesis

Mesh:

Substances:

Year:  2018        PMID: 30554970     DOI: 10.1016/j.bmc.2018.12.003

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

1.  The Clinical Effects of Metronidazole Vaginal Effervescent Tablets Combined with Kushen Suppository in the Treatment of Trichomonas Vaginitis.

Authors:  Hongxia Zhang; Zeng Jing; Feng Li; Benming Yue; Ping Zhang; Hui Li
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-12       Impact factor: 2.650

2.  New Metallophthalocyanines Bearing 2-Methylimidazole Moieties-Potential Photosensitizers against Staphylococcus aureus.

Authors:  Marcin Wierzchowski; Daniel Ziental; Dawid Łażewski; Artur Korzanski; Agnieszka Gielara-Korzanska; Ewa Tykarska; Jolanta Dlugaszewska; Lukasz Sobotta
Journal:  Int J Mol Sci       Date:  2022-05-25       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.